• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday

    9/8/22 5:26:06 AM ET
    $ADTH
    $AKA
    $AMRS
    $AQST
    Computer Software: Programming Data Processing
    Technology
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $ADTH alert in real time by email

    Gainers

    • IMARA Inc. (NASDAQ:IMRA) jumped 74.8% to settle at $2.01 on Wednesday after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront.
    • Azure Power Global Limited (NYSE:AZRE) shares jumped 35.4% to close at $4.86. Azure Power Global recently announced the resignation of Harsh Shah as CEO.
    • SelectQuote, Inc. (NYSE:SLQT) rose 28.8% to close at $1.43.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) gained 27.7% to close at $36.40 amid post-IPO volatility.
    • Spero Therapeutics, Inc. (NASDAQ:SPRO) shares jumped 26.6% to close at $1.43. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.
    • a.k.a. Brands Holding Corp. (NYSE:AKA) gained 23.7% to settle at $2.92 amid overall market strength as stocks rebound from recent weakness.
    • Pingtan Marine Enterprise Ltd. (NASDAQ:PME) climbed 23.3% to close at $0.8998.
    • Nutex Health, Inc. (NASDAQ:NUTX) gained 21.9% to close at $3.17.
    • Molecular Templates, Inc. (NASDAQ:MTEM) rose 21.8% to close at $0.83. Molecular Templates said on August 31, it received notice from Nasdaq that the company no longer meets minimum bid price requirement.
    • Reata Pharmaceuticals, Inc. (NASDAQ:RETA) jumped 21.1% to settle at $27.07.
    • Amyris, Inc. (NASDAQ:AMRS) gained 19.6% to settle at $3.24.
    • Latch, Inc. (NASDAQ:LTCH) jumped 19.2% to close at $1.24.
    • Tupperware Brands Corporation (NYSE:TUP) gained 19.2% to settle at $8.77 amid overall market strength as stocks rebound from recent weakness.
    • Vicarious Surgical Inc. (NASDAQ:RBOT) rose 18.8% to close at $4.37. Vicarious Surgical, last month, posted a Q2 loss of $0.16 per share.
    • Biophytis S.A. (NASDAQ:BPTS) shares gained 18.1% to close at $1.11 after the company released topline results from its phase 2-3 COVA study evaluating Sarconeos (BIO101) in treating COVID-19-related respiratory failure.
    • Glaukos Corporation (NYSE:GKOS) climbed 18.5% to close at $57.01 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary efficacy endpoints through 3 months in both Phase 3 trials and demonstrated excellent tolerability and a favorable safety profile through 12 months.
    • Coupa Software Incorporated (NASDAQ:COUP) jumped 17.9% to close at $65.82 as the company posted better-than-expected results for its second quarter and issued strong forecast for FY23. The company also announced a $100 million buyback program.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares gained 17.8% to close at $3.91 after Alliance Global Partners initiated coverage on the stock with a Buy rating and a $20 price target.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) rose 17.6% to close at $1.47. Oppenheimer initiated coverage on Aquestive Therapeutics with an Outperform rating and announced a price target of $8.5.
    • Seres Therapeutics, Inc. (NASDAQ:MCRB) rose 17% to close at $6.32. Seres Therapeutics announced completion of rolling BLA submission to the FDA for investigational microbiome therapeutic SER-109 for recurrent C. Difficile infection.
    • SAI.TECH Global Corporation (NASDAQ:SAI) jumped 15.3% to close at $5.42.
    • Sidus Space, Inc. (NASDAQ:SIDU) gained 14.7% to close at $3.05 after the company announced that it has signed a launch agreement with SpaceX for five launches, beginning in early 2023.
    • GitLab Inc. (NASDAQ:GTLB) surged 14.3% to settle at $54.16 following Q2 results.
    • SunPower Corporation (NASDAQ:SPWR) gained 14.4% to close at $27.37.
    • Academy Sports and Outdoors, Inc. (NASDAQ:ASO) jumped 14% to close at $47.81. Academy Sports And Outdoors reported a second-quarter FY22 sales decline of 5.8% year-on-year to $1.69 billion.
    • Penumbra, Inc. (NYSE:PEN) gained 13.2% to close at $185.90. Penumbra, last month, reported better-than-expected Q2 EPS and sales results.
    • Baudax Bio, Inc. (NASDAQ:BXRX) rose 12.9% to close at $0.3399 after declining over 7% on Tuesday. Baudax Bio recently announced the pricing of a $6.2 million public offering.
    • SolarEdge Technologies, Inc. (NASDAQ:SEDG) jumped 11.9% to close at $311.36. Shares of several solar companies at large traded higher in possible reaction to the recent signing of the Inflation Reduction Act. The European gas crisis could also be positively impacting solar stocks, as countries look for alternatives to gas.
    • Tempur Sealy International, Inc. (NYSE:TPX) gained 11.6% to settle at $27.24.
    • Unico American Corporation (NASDAQ:UNAM) gained 9.5% to close at $1.84.
    • bioAffinity Technologies, Inc. (NASDAQ:BIAF) gained 6.7% to close at $5.75 after dropping around 24% on Tuesday. The company, last week, priced its IPO at $6.125 per unit.

     

     

    Losers

    • Great Panther Mining Limited (NYSE:GPL) dipped 60.1% to close at $0.3232 on Wednesday. Great Panther recently announced it will file a notice of intention to make a proposal under the Bankruptcy and Insolvency Act (Canada).
    • CleanTech Acquisition Corp. (NASDAQ:CLAQ) shares fell 28.5% to close at $6.77 after the company reported shareholder voting results in 8K filing.
    • NewAge, Inc. (NASDAQ:NBEV) shares fell 25.2% to close at $0.0935 after dipping over 15% on Tuesday. The company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares fell 23.2% to close at $3.24 after jumping around 33% on Tuesday. First Wave BioPharma recently announced a 1:30 reverse stock split.
    • Veru Inc. (NASDAQ:VERU) declined 21.1% to close at $11.51. Traders circulate word FDA decision on the company’s COVID treatment coming on Oct. 6.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) dropped 18.8% to settle at $0.8201.
    • Presidio Property Trust, Inc. (NASDAQ:SQFT) fell 16.8% to close at $1.73. Presidio Property Trust recently declared Q3 dividend and adopted variable dividend policy.
    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) dropped 15% to settle at $4.99.
    • AdTheorent Holding Company, Inc. (NASDAQ:ADTH) fell 15% to close at $2.32.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) declined 14.8% to close at $0.1875. American Virtual Cloud Technologies recently announced an equity distribution agreement to offer and sell up to $14.7 million shares of common stock.
    • Golden Path Acquisition Corporation (NASDAQ:GPCO) dropped 13.4% to close at $8.88.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) fell 12.2% to close at $2.23.
    • FaZe Holdings Inc. (NASDAQ:FAZE) fell 11.9% to close at $12.10.
    • Korn Ferry (NYSE:KFY) fell 11.6% to close at $53.24 following downbeat quarterly earnings.
    • UiPath Inc. (NYSE:PATH) fell 11.2% to close at $13.84 after the company issued Q3 and FY23 sales guidance below analyst estimates.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) dropped 10.3% to close at $2.45.
    • John Wiley & Sons, Inc. (NYSE:WLY) fell 9.8% to close at $41.58 after the company reported worse-than-expected Q1 EPS and sales results.
    • Vacasa, Inc. (NASDAQ:VCSA) fell 8.4% to close at $3.69.
    • Cogent Communications Holdings, Inc. (NASDAQ:CCOI) declined 8.3% to close at $49.63. Cogent Communications agreed to snap T-Mobile US, Inc's (NASDAQ:TMUS) Wireline Business.
    • AMTD Digital Inc. (NYSE:HKD) dropped 8.2% to settle at $63.27.
    • Vermilion Energy Inc. (NYSE:VET) fell 7.6% to close at $23.26 amid a drop in oil prices as economic concerns weigh on demand outlook.
    • G-III Apparel Group, Ltd. (NASDAQ:GIII) dropped 5.6% to close at $18.73 after the company posted downbeat quarterly earnings and lowered FY23 forecast.
    • GameStop Corp. (NYSE:GME) fell 4.4% to close at $24.04. The company released quarterly earnings after the closing bell on Wednesday.
    Get the next $ADTH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTH
    $AKA
    $AMRS
    $AQST

    CompanyDatePrice TargetRatingAnalyst
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    SolarEdge Technologies Inc.
    $SEDG
    1/13/2026Mkt Perform
    Raymond James
    GitLab Inc.
    $GTLB
    1/12/2026$34.00Equal Weight → Underweight
    Barclays
    GitLab Inc.
    $GTLB
    1/12/2026$42.00Overweight → Equal-Weight
    Morgan Stanley
    SolarEdge Technologies Inc.
    $SEDG
    1/9/2026$38.00Hold → Buy
    TD Cowen
    GitLab Inc.
    $GTLB
    1/7/2026$40.00Overweight → Neutral
    Cantor Fitzgerald
    Veru Inc.
    $VERU
    12/18/2025$25.00Buy
    Canaccord Genuity
    Avalo Therapeutics Inc.
    $AVTX
    12/18/2025$39.00Outperform
    Mizuho
    More analyst ratings

    $ADTH
    $AKA
    $AMRS
    $AQST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Director Attal Alain bought $259,577 worth of shares (12,000 units at $21.63), increasing direct ownership by 2% to 596,464 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/21/26 6:32:09 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ADTH
    $AKA
    $AMRS
    $AQST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    T-Mobile Announces Proposed Public Offering of Euro-Denominated Senior Notes

    T-Mobile US, Inc. (NASDAQ:TMUS) ("T-Mobile") announced today that T-Mobile USA, Inc., its direct wholly-owned subsidiary ("T-Mobile USA" or the "Issuer"), plans to offer, subject to market and other conditions, euro-denominated senior notes (the "notes") in a registered public offering. T-Mobile USA intends to use the net proceeds from the offering for general corporate purposes, which may include among other things, share repurchases, any dividends declared by T-Mobile's Board of Directors and refinancing of existing indebtedness on an ongoing basis. Barclays Bank PLC, BNP PARIBAS, Crédit Agricole Corporate and Investment Bank, Goldman Sachs & Co. LLC and Morgan Stanley & Co. Internation

    2/12/26 3:13:00 AM ET
    $TMUS
    Telecommunications Equipment
    Telecommunications

    UiPath Announces Fourth Quarter and Full Year Fiscal 2026 Financial Results Conference Call

    UiPath, Inc. (NYSE:PATH), a global leader in agentic automation, today announced it will report financial results for its fourth quarter and full year fiscal 2026 ended January 31, 2026 after the market closes on Wednesday, March 11, 2026. Management will host a conference call and webcast to discuss the Company's financial results at 5:00 pm ET. UiPath Fourth Quarter and Full Year Fiscal 2026 Financial Results Conference Call When: Wednesday, March 11, 2026 Time: 5:00 pm ET Conference ID: 13758276 Live Call: 1-877-407-8309 (US/Canada Toll-Free) or 1-201-689-8057 (Toll) Replay: A webcast replay of the conference call will be available on the investor relations website for one year. Webcas

    2/11/26 4:10:00 PM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    T-Mobile Raises the Bar, Increasing Its Multi-Year Growth Outlook, Fueled by Widening and Durable Differentiation Across America's Best Network, Best Value, and Best Customer Experiences With Unparalleled Growth Opportunities

    Differentiated value proposition with no trade-offs expected to deliver continued outsized profitable customer account and financial growth exceeding original 2024 Capital Markets Day plan, including a new target of 18–19 million total broadband customers by 2030, comprising 15 million 5G broadband and 3–4 million T-Fiber customers, translating to accelerating growth in service revenues and Core Adjusted EBITDA1, including a nearly $3 billion incremental contribution to Core Adjusted EBITDA expected from digitalization and AI, by the end of 2027, relative to 2025, while maintaining an industry-leading Adjusted Free Cash Flow margin During its fourth quarter 2025 earnings call and Capital

    2/11/26 9:49:00 AM ET
    $TMUS
    Telecommunications Equipment
    Telecommunications

    $ADTH
    $AKA
    $AMRS
    $AQST
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IDOSE TR issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug IDOSE TR (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/15/23 11:41:09 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    FDA Approval for TRAVOPROST issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug TRAVOPROST (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/14/23 7:41:03 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $ADTH
    $AKA
    $AMRS
    $AQST
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Quoin Pharmaceuticals Ltd.

    SCHEDULE 13G/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Subject)

    2/11/26 5:10:41 PM ET
    $QNRX
    Medical/Dental Instruments
    Health Care

    SEC Form IRANNOTICE filed by T-Mobile US Inc.

    IRANNOTICE - T-Mobile US, Inc. (0001283699) (Filer)

    2/11/26 4:06:52 PM ET
    $TMUS
    Telecommunications Equipment
    Telecommunications

    SEC Form 10-K filed by T-Mobile US Inc.

    10-K - T-Mobile US, Inc. (0001283699) (Filer)

    2/11/26 4:05:38 PM ET
    $TMUS
    Telecommunications Equipment
    Telecommunications

    $ADTH
    $AKA
    $AMRS
    $AQST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on Avalo Therapeutics with a new price target

    Guggenheim initiated coverage of Avalo Therapeutics with a rating of Buy and set a new price target of $50.00

    2/2/26 6:51:00 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Raymond James initiated coverage on SolarEdge Technologies

    Raymond James initiated coverage of SolarEdge Technologies with a rating of Mkt Perform

    1/13/26 9:17:42 AM ET
    $SEDG
    Semiconductors
    Technology

    GitLab downgraded by Barclays with a new price target

    Barclays downgraded GitLab from Equal Weight to Underweight and set a new price target of $34.00

    1/12/26 8:05:47 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ADTH
    $AKA
    $AMRS
    $AQST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHAIRMAN & CEO Burns Thomas William received a gift of 67,353 shares, exercised 166,000 shares at a strike of $30.92 and gifted 67,353 shares, increasing direct ownership by 63% to 255,621 units (SEC Form 4)

    4 - GLAUKOS Corp (0001192448) (Issuer)

    2/10/26 8:14:18 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    Officer Rajavelu Esther sold $207,484 worth of shares (87,917 units at $2.36), decreasing direct ownership by 8% to 1,012,091 units (SEC Form 4)

    4 - Spero Therapeutics, Inc. (0001701108) (Issuer)

    2/9/26 9:31:37 PM ET
    $SPRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Operating Officer Keutzer Timothy sold $44,019 worth of shares (18,652 units at $2.36), decreasing direct ownership by 2% to 742,506 units (SEC Form 4)

    4 - Spero Therapeutics, Inc. (0001701108) (Issuer)

    2/9/26 9:09:39 PM ET
    $SPRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTH
    $AKA
    $AMRS
    $AQST
    Leadership Updates

    Live Leadership Updates

    View All

    Cineverse and GameStop Invite Fans to 'Return to Silent Hill' with Innovative Partnership featuring Mysterious Messages, Exclusive Rewards, In-Store Media & More

    Return to Silent Hill Hits Theaters Nationwide on January 23 – Buy Tickets Now LOS ANGELES and GRAPEVINE, Texas, Jan. 14, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next generation entertainment studio, and GameStop Corp. (NYSE:GME), are pulling out all the stops in anticipation of the January 23 wide theatrical release of Return to Silent Hill (returntosilenthillmovie.com).  The two companies are collaborating on an immersive marketing campaign for the new film, based on the visionary video game, SILENT HILL 2. Since January 7, fans who visit a participating GameStop ca

    1/14/26 3:02:00 PM ET
    $CNVS
    $GME
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Electronics Distribution

    Wiley Appoints Armughan Rafat as Chief AI and Data Services Officer

    Proven Leader to Accelerate Wiley's AI Momentum and Growth in Corporate R&D Markets Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced the appointment of Armughan Rafat as chief AI and data services officer. Rafat will lead Wiley's AI and data services initiatives, focusing on developing and commercializing AI-ready content and data products for AI developers and corporate R&D teams. He will report to President and CEO Matt Kissner and join the company's Executive Leadership Team. Rafat has a proven track record as an innovator responsible for building high-margin bu

    1/13/26 8:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    GitLab Appoints Siva Padisetty as Chief Technology Officer

    Veteran engineering leader brings two decades of experience scaling cloud platforms and modernizing enterprise systems All-Remote - GitLab Inc., the most comprehensive intelligent DevSecOps platform, today announced the appointment of Siva Padisetty as Chief Technology Officer, effective January 15, 2026. Padisetty will lead GitLab's software engineering, operations, and customer support teams to execute the company's technical vision and strategy and oversee the development and delivery of GitLab's products. He succeeds Sabrina Farmer, who stepped down from her role and will remain in an advisory capacity to ensure a seamless transition through January 31, 2026. This press release featu

    1/12/26 9:05:00 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ADTH
    $AKA
    $AMRS
    $AQST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Latch Inc.

    SC 13G - Latch, Inc. (0001826000) (Subject)

    12/13/24 9:45:09 PM ET
    $LTCH
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Latch Inc.

    SC 13D/A - Latch, Inc. (0001826000) (Subject)

    12/2/24 4:44:02 PM ET
    $LTCH
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Molecular Templates Inc.

    SC 13G/A - Molecular Templates, Inc. (0001183765) (Subject)

    11/18/24 9:49:56 PM ET
    $MTEM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTH
    $AKA
    $AMRS
    $AQST
    Financials

    Live finance-specific insights

    View All

    UiPath Announces Fourth Quarter and Full Year Fiscal 2026 Financial Results Conference Call

    UiPath, Inc. (NYSE:PATH), a global leader in agentic automation, today announced it will report financial results for its fourth quarter and full year fiscal 2026 ended January 31, 2026 after the market closes on Wednesday, March 11, 2026. Management will host a conference call and webcast to discuss the Company's financial results at 5:00 pm ET. UiPath Fourth Quarter and Full Year Fiscal 2026 Financial Results Conference Call When: Wednesday, March 11, 2026 Time: 5:00 pm ET Conference ID: 13758276 Live Call: 1-877-407-8309 (US/Canada Toll-Free) or 1-201-689-8057 (Toll) Replay: A webcast replay of the conference call will be available on the investor relations website for one year. Webcas

    2/11/26 4:10:00 PM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    T-Mobile Raises the Bar, Increasing Its Multi-Year Growth Outlook, Fueled by Widening and Durable Differentiation Across America's Best Network, Best Value, and Best Customer Experiences With Unparalleled Growth Opportunities

    Differentiated value proposition with no trade-offs expected to deliver continued outsized profitable customer account and financial growth exceeding original 2024 Capital Markets Day plan, including a new target of 18–19 million total broadband customers by 2030, comprising 15 million 5G broadband and 3–4 million T-Fiber customers, translating to accelerating growth in service revenues and Core Adjusted EBITDA1, including a nearly $3 billion incremental contribution to Core Adjusted EBITDA expected from digitalization and AI, by the end of 2027, relative to 2025, while maintaining an industry-leading Adjusted Free Cash Flow margin During its fourth quarter 2025 earnings call and Capital

    2/11/26 9:49:00 AM ET
    $TMUS
    Telecommunications Equipment
    Telecommunications

    T-Mobile Delivers Best-in-Class Customer Results in Q4, Translating into Durable and Profitable Financial Growth Driven By Widening Differentiation

    Q4 Yet Another Proof Point of the Un-carrier's Widening Pillars of Differentiation Leading to Sustained Outperformance, Including First-Ever J.D. Power Award for Highest Network Quality, Positioning T-Mobile for Continued Profitable Growth in 2026 and Beyond T-Mobile US, Inc. (NASDAQ:TMUS): Industry-Leading Customer Growth Fueled by Widening Differentiation in Best Network, Best Value and Best Experiences Combination(1) Total postpaid net customer additions of 2.4 million in Q4 2025 and 7.8 million in 2025, both industry best Postpaid phone net customer additions of 962 thousand in Q4 2025 and 3.3 million in 2025, both industry best Postpaid net account additions of 261 thousan

    2/11/26 7:35:00 AM ET
    $TMUS
    Telecommunications Equipment
    Telecommunications